MyD88, but Not Toll-like Receptors 4 and 2, is Required for Efficient Clearance of Brucella Abortus

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2005 Jul 26

PMID 16041030

Citations 45

Authors

David S Weiss

Kiyoshi Takeda

Shizuo Akira

Arturo Zychlinsky

Edgardo Moreno

Affiliations

Soon will be listed here.

Abstract

It is not clear how the host initially recognizes and responds to infection by gram-negative pathogenic Brucella spp. It was previously shown (D. S. Weiss, B. Raupach, K. Takeda, S. Akira, and A. Zychlinsky, J. Immunol. 172:4463-4469, 2004) that the early macrophage response against gram-negative bacteria is mediated by Toll-like receptor 4 (TLR4), which signals in response to lipopolysaccharide (LPS). Brucella, however, has a noncanonical LPS which does not have potent immunostimulatory activity. We evaluated the kinetics of TLR4 activation and the cytokine response in murine macrophages after Brucella infection. We found that during infection of macrophages, Brucella avoids activation of TLR4 at 6 h but activates TLR4, TLR2, and myeloid differentiation factor 88 (MyD88) at 24 h postinfection. Interestingly, even though its activation is delayed, MyD88 is important for host defense against Brucella infection in vivo, since MyD88(-/-) mice do not clear the bacteria as efficiently as wild-type, TLR4(-/-), TLR2(-/-), or TLR4/TLR2(-/-) mice.

Citing Articles

triggers the differential expression of immunomodulatory lncRNAs in infected murine macrophages.

Flores-Concha M, Gomez L, Soto-Shara R, Molina R, Coloma-Rivero R, Montero D Front Immunol. 2024; 15:1352306.

PMID: 38464511 PMC: 10921354. DOI: 10.3389/fimmu.2024.1352306.

Phagocytosis Mediated by Pathogen-Host Interactions and Their Intracellular Survival.

Huy T, Nguyen T, Kim H, Reyes A, Kim S Microorganisms. 2022; 10(10).

PMID: 36296279 PMC: 9610446. DOI: 10.3390/microorganisms10102003.

Immunosuppressive Mechanisms in Brucellosis in Light of Chronic Bacterial Diseases.

Pellegrini J, Gorvel J, Memet S Microorganisms. 2022; 10(7).

PMID: 35888979 PMC: 9324529. DOI: 10.3390/microorganisms10071260.

Key immunity characteristics of diverse stages of brucellosis in rural population from Inner Mongolia, China.

Zhu Y, Shi L, Zeng Y, Piao D, Xie Y, Du J Infect Dis Poverty. 2022; 11(1):63.

PMID: 35659087 PMC: 9167523. DOI: 10.1186/s40249-022-00989-7.

Protection of palmitic acid treatment in RAW264.7 cells and BALB/c mice during 544 infection.

Reyes A, Huy T, Vu S, Kim H, Lee J, Choi J J Vet Sci. 2021; 22(2):e18.

PMID: 33774934 PMC: 8007444. DOI: 10.4142/jvs.2021.22.e18.

References

Campos M, Rosinha G, Almeida I, Salgueiro X, Jarvis B, Splitter G . Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice. Infect Immun. 2003; 72(1):176-86. PMC: 344000. DOI: 10.1128/IAI.72.1.176-186.2004. View

Aliprantis A, Yang R, Mark M, Suggett S, Devaux B, Radolf J . Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science. 1999; 285(5428):736-9. DOI: 10.1126/science.285.5428.736. View

Weiss D, Raupach B, Takeda K, Akira S, Zychlinsky A . Toll-like receptors are temporally involved in host defense. J Immunol. 2004; 172(7):4463-9. DOI: 10.4049/jimmunol.172.7.4463. View

Moriyon I, Grillo M, Monreal D, Gonzalez D, Marin C, Lopez-Goni I . Rough vaccines in animal brucellosis: structural and genetic basis and present status. Vet Res. 2004; 35(1):1-38. DOI: 10.1051/vetres:2003037. View

Akira S, Takeda K . Toll-like receptor signalling. Nat Rev Immunol. 2004; 4(7):499-511. DOI: 10.1038/nri1391. View

Duenas A, Orduna A, Sanchez Crespo M, Garcia-Rodriguez C . Interaction of endotoxins with Toll-like receptor 4 correlates with their endotoxic potential and may explain the proinflammatory effect of Brucella spp. LPS. Int Immunol. 2004; 16(10):1467-75. DOI: 10.1093/intimm/dxh148. View

Giambartolomei G, Zwerdling A, Cassataro J, Bruno L, Fossati C, Philipp M . Lipoproteins, not lipopolysaccharide, are the key mediators of the proinflammatory response elicited by heat-killed Brucella abortus. J Immunol. 2004; 173(7):4635-42. DOI: 10.4049/jimmunol.173.7.4635. View

Moreno E, Pitt M, Jones L, Schurig G, BERMAN D . Purification and characterization of smooth and rough lipopolysaccharides from Brucella abortus. J Bacteriol. 1979; 138(2):361-9. PMC: 218186. DOI: 10.1128/jb.138.2.361-369.1979. View

Moreno E, BERMAN D, Boettcher L . Biological activities of Brucella abortus lipopolysaccharides. Infect Immun. 1981; 31(1):362-70. PMC: 351792. DOI: 10.1128/iai.31.1.362-370.1981. View

10.

Hoiseth S, Stocker B . Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature. 1981; 291(5812):238-9. DOI: 10.1038/291238a0. View

11.

Moreno E, Kurtz R, BERMAN D . Induction of immune and adjuvant immunoglobulin G responses in mice by Brucella lipopolysaccharide. Infect Immun. 1984; 46(1):74-80. PMC: 261423. DOI: 10.1128/iai.46.1.74-80.1984. View

12.

Moreno E, Stackebrandt E, Dorsch M, Wolters J, Busch M, Mayer H . Brucella abortus 16S rRNA and lipid A reveal a phylogenetic relationship with members of the alpha-2 subdivision of the class Proteobacteria. J Bacteriol. 1990; 172(7):3569-76. PMC: 213329. DOI: 10.1128/jb.172.7.3569-3576.1990. View

13.

Goldstein J, Hoffman T, Frasch C, Lizzio E, BEINING P, Hochstein D . Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines. Infect Immun. 1992; 60(4):1385-9. PMC: 257008. DOI: 10.1128/iai.60.4.1385-1389.1992. View

14.

Rasool O, Freer E, Moreno E, Jarstrand C . Effect of Brucella abortus lipopolysaccharide on oxidative metabolism and lysozyme release by human neutrophils. Infect Immun. 1992; 60(4):1699-702. PMC: 257051. DOI: 10.1128/iai.60.4.1699-1702.1992. View

15.

Zheng H, Fletcher D, Kozak W, Jiang M, Hofmann K, Conn C . Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice. Immunity. 1995; 3(1):9-19. DOI: 10.1016/1074-7613(95)90154-x. View

16.

Kawai T, Adachi O, Ogawa T, Takeda K, Akira S . Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 1999; 11(1):115-22. DOI: 10.1016/s1074-7613(00)80086-2. View

17.

Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T . Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 1999; 11(4):443-51. DOI: 10.1016/s1074-7613(00)80119-3. View

18.

Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M . Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol. 2000; 164(7):3476-9. DOI: 10.4049/jimmunol.164.7.3476. View

19.

Fitzgerald K, Palsson-McDermott E, Bowie A, Jefferies C, Mansell A, Brady G . Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature. 2001; 413(6851):78-83. DOI: 10.1038/35092578. View

20.

Gorvel J, Moreno E . Brucella intracellular life: from invasion to intracellular replication. Vet Microbiol. 2002; 90(1-4):281-97. DOI: 10.1016/s0378-1135(02)00214-6. View